Clinical Trial Update: Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices

View source ↗

Summary

A clinical trial evaluating subcutaneous immunoglobulin therapy for Chronic Inflammatory Demyelinating Polyneuropathy with effectiveness monitoring using smart …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Drugs mentioned

• Subcutaneous immunoglobulin therapy (immunoglobulin (IgG))

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: CIDP - Chronic Inflammatory Demyelinating Polyneuropathy | Status: RECRUITING